Thursday, December 29, 2005


Hepatitis C - Hepatitis C


Hepatitis C
Title: Hepatitis CCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Shorter Therapy Effective for Genotypes 2 and 3
Genotypes 2 and 3 are much more responsive to current interferon combination therapies. This report details studies that show a shorter course of treatment might be just as effective as longer courses. Researchers continue to refine treatment protocols for HCV...

Two Studies Recruiting HCV Patients
Sho-saiko-to is the number one liver remedy in Japan. It has been prescribed to over 1.5 million patients (in Japan, doctors medically prescribe certain natural remedies, just like doctors prescribe pharmaceutical drugs in the U.S.). Based on the large body...

Doctor: Getting the Most from Your Doctor s Appointment
Title: Doctor: Getting the Most from Your Doctor s AppointmentCategory: Doctor's ViewsCreated: 5/13/2005Last Editorial Review: 5/13/2005

Your Results May Vary For HCV Treatment
According to this study, actual treatment results may be only half as good as touted. Doctors tend to trust the numbers presented by the pharaceutical companies. The pharmaceutical companies have a vested interest in presenting the best numbers they can...

Indenix is Nearing Phase III for Valopicitabine
It is always good to see progress with alternatives to current medical therapy for HCV. Even though companies that are working on solutions to be used with interferon are not really offering anything groundbreaking or revolutionary, it does continue the...